Drugs / PF-04856883
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01637285 | Aug 2012 → Jan 2013 | — | Pfizer | Completed | No outcome recorded |
| Phase 1 | NCT01301456 | Mar → Dec 2011 | type 2 diabetes mellitus | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-04856883 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01301456 ↗ |
| Known as | CVX-096 | “A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers” NCT01637285 ↗ |
| Route | Subcutaneous | “Single subcutaneous injection of PF-04856883” NCT01301456 ↗ |